Goldman Sachs Group Inc Novartis Ag Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Novartis Ag stock. As of the latest transaction made, Goldman Sachs Group Inc holds 3,486,231 shares of NVS stock, worth $359 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,486,231
Previous 3,081,076 13.15%
Holding current value
$359 Million
Previous $328 Million 22.25%
% of portfolio
0.07%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $43 Million - $49 Million
405,155 Added 13.15%
3,486,231 $401 Million
Q2 2024

Aug 13, 2024
BUY
$92.57 - $107.37 $2.01 Million - $2.33 Million
21,715 Added 0.71%
3,081,076 $328 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $45.4 Million - $51.7 Million
-476,541 Reduced 13.48%
3,059,361 $296 Million
Q4 2023

Feb 13, 2024
BUY
$92.27 - $101.54 $70.3 Million - $77.3 Million
761,545 Added 27.45%
3,535,902 $357 Million
Q3 2023

May 14, 2024
SELL
$94.73 - $105.13 $72.1 Million - $80.1 Million
-761,545 Reduced 21.54%
2,774,357 $283 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $11.7 Million - $12.9 Million
-123,107 Reduced 4.25%
2,774,357 $283 Million
Q2 2023

May 14, 2024
SELL
$92.52 - $104.91 $162 Million - $183 Million
-1,747,915 Reduced 37.63%
2,897,464 $292 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $162 Million - $183 Million
-1,747,915 Reduced 37.63%
2,897,464 $292 Million
Q1 2023

May 14, 2024
BUY
$80.03 - $92.81 $222 Million - $257 Million
2,768,876 Added 147.56%
4,645,379 $427 Million
Q1 2023

May 11, 2023
BUY
$80.03 - $92.81 $222 Million - $257 Million
2,768,876 Added 147.56%
4,645,379 $427 Million
Q4 2022

May 14, 2024
SELL
$75.55 - $92.52 $61.1 Million - $74.8 Million
-808,960 Reduced 30.12%
1,876,503 $170 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $61.1 Million - $74.8 Million
-808,960 Reduced 30.12%
1,876,503 $170 Million
Q3 2022

May 14, 2024
BUY
$74.61 - $87.26 $3.74 Million - $4.37 Million
50,131 Added 1.9%
2,685,463 $204 Million
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $3.74 Million - $4.37 Million
50,131 Added 1.9%
2,685,463 $204 Million
Q2 2022

May 14, 2024
SELL
$80.52 - $93.75 $72.5 Million - $84.4 Million
-900,570 Reduced 25.47%
2,635,332 $223 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $11.8 Million - $13.7 Million
-146,264 Reduced 5.26%
2,635,332 $223 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $47.6 Million - $53.8 Million
594,194 Added 27.16%
2,781,596 $244 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $8.68 Million - $9.6 Million
108,936 Added 5.24%
2,187,402 $191 Million
Q3 2021

Nov 10, 2021
BUY
$81.78 - $95.14 $170 Million - $198 Million
2,078,466 New
2,078,466 $170 Million

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email